Search
4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
go.drugbank.com/drugs/DB02565ExperimentalSynonyms: 4-dimethylamino-N-(6-hydroxycarbamoylhexyl)benzamide, N-hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamideResmetirom
go.drugbank.com/drugs/DB12914ApprovedInvestigationalResmetirom is a thyroid hormone receptor-beta (THR-beta) agonist. … On March 14, 2024, it was approved by the FDA as the first treatment of liver fibrosis due to noncirrhotic non-alcoholic steatohepatitis (NASH), which is a form of non-alcoholic fatty liver disease (NAFLD
Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 1-RingSynonyms: 1,2,4-Triazine-6-carbonitrile, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-, 2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carbonitrileTyrosol
go.drugbank.com/drugs/DB16855ExperimentalSynonyms: 4-Hydroxyphenylethanol, 4-Hydroxyphenethyl alcoholCategories: Compounds used in a research, industrial, or household setting, Cytochrome P-450 SubstratesTravoprost
go.drugbank.com/drugs/DB00287ApprovedInvestigational[L49434] Unlike other prostaglandin analogues, travoprost demonstrates full agonism and high selectivity at the prostanoid receptor, reporting a higher efficacy in reducing intraocular pressure and a reduced … Travoprost is a synthetic isopropyl ester prodrug of a prostaglandin F2alpha (F2α) analogue and selective FP prostanoid receptor agonist.
Synonyms: isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(α,α,α-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate, ISOPROPYL (Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATEInternational brands: Travo-ZEmtricitabine
go.drugbank.com/drugs/DB00879ApprovedInvestigationalEmtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) indicated for the treatment of HIV infection in adults[L9019] or combined with [tenofovir alafenamide] for the prevention of HIV-1 infection … [L9019] Emtricitabine was granted FDA approval on 2 July 2003.[L9019]
Mixtures: TENOHOPE E (EMTRICITABINE 200 MG & TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS), EMTRICITABINA E TENOFOVIR DISOPROXIL EGCategories: MATE 1 Substrates, Heterocyclic Compounds, 1-RingAMG-900
go.drugbank.com/drugs/DB17197ExperimentalSalts: AMG-900 bismesylate dihydrateCategories: Heterocyclic Compounds, 1-RingCumidine
go.drugbank.com/drugs/DB02114ExperimentalSynonyms: 4-(1-methylethyl)aniline, 4-Amino-1-isopropylbenzeneFK-960
go.drugbank.com/drugs/DB06465ExperimentalSynonyms: N-(4-Acetyl-1-piperazinyl)-4-fluorobenzamideCategories: Heterocyclic Compounds, 1-Ringp-Cumylphenol
go.drugbank.com/drugs/DB06902ExperimentalSynonyms: 4-Cumylphenol, 4-(alpha,alpha-Dimethylbenzyl)phenolOxabolone
go.drugbank.com/drugs/DB01500ExperimentalIllicitSynonyms: 4-hydroxy nandrolone, 4-hydroxy-19-nortestosterone